Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.11 USD | -7.86% | -18.53% | -39.75% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.8M |
---|---|---|---|---|---|
Net income 2024 * | -16M | Net income 2025 * | -21M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.47
x | P/E ratio 2025 * |
-0.43
x | Employees | 17 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.41% |
Latest transcript on TRACON Pharmaceuticals, Inc.
1 day | -7.86% | ||
1 week | -18.53% | ||
Current month | -75.45% | ||
1 month | -70.78% | ||
3 months | -30.91% | ||
6 months | -34.96% | ||
Current year | -39.75% |
Managers | Title | Age | Since |
---|---|---|---|
Charles Theuer
CEO | Chief Executive Officer | 60 | 06-06-30 |
Scott Brown
DFI | Director of Finance/CFO | 43 | 15-07-31 |
James L. Freddo
CTO | Chief Tech/Sci/R&D Officer | 69 | 20-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Mattingly
BRD | Director/Board Member | 66 | 14-12-25 |
Director/Board Member | 54 | 20-03-18 | |
Stephen Worland
BRD | Director/Board Member | 66 | 15-02-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 2.11 | -7.86% | 353,032 |
24-04-17 | 2.29 | +33.92% | 2,023,692 |
24-04-16 | 1.71 | -5.00% | 264,946 |
24-04-15 | 1.8 | -23.73% | 254,190 |
24-04-12 | 2.36 | -8.88% | 344,803 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.75% | 5.21M | |
-5.96% | 84.57B | |
+3.95% | 39.93B | |
-26.37% | 27.93B | |
+52.09% | 24.21B | |
-6.59% | 17.17B | |
-32.37% | 13.93B | |
-10.45% | 12.3B | |
-15.88% | 11.84B | |
-2.85% | 7.91B |
- Stock Market
- Equities
- TCON Stock